Data / Form D filings / VITANOVA BIOMEDICAL, INC.
VITANOVA BIOMEDICAL, INC.: Form D filings
VITANOVA BIOMEDICAL, INC., a biotechnology company in Kerrville, TX, filed 6 Form D notices with the SEC between 2019 and 2021. The latest, on June 8, 2021, reports $325,000 sold of a $6.5 million offering to 5 investors.
Find out what VITANOVA BIOMEDICAL, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 222 SIDNEY BAKER ST., SUITE 635, Kerrville, TX, 78028
- Phone
- (317) 730-5955
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1776700
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2021 | Amendment | $6,500,000 | $325,000 | $6,175,000 | 5 | Aug 26, 2019 | sec.gov |
| Aug 20, 2020 | Amendment | $5,000,000 | $325,000 | $4,675,000 | 5 | Aug 26, 2019 | sec.gov |
| Aug 28, 2019 | New notice | $5,000,000 | $100,000 | $4,900,000 | 1 | Aug 26, 2019 | sec.gov |
| Aug 27, 2019 | Amendment | $420,000 | $420,000 | $0 | 8 | Feb 1, 2018 | sec.gov |
| Aug 21, 2019 | Amendment | $420,000 | $420,000 | $0 | 8 | Feb 1, 2018 | sec.gov |
| May 14, 2019 | New notice | $420,000 | $420,000 | $0 | 8 | Feb 1, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MATTHEW C/O VITANOVA BIOMEDICAL, INC. GDOVIN | Executive Officer, Director | |
| GREG C/O VITANOVA BIOMEDICAL, INC. ESPENHOVER | Executive Officer, Director | |
| THOMAS C/O VITANOVA BIOMEDICAL, INC. ROBERTS | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 7, 2021 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VITANOVA BIOMEDICAL, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.